SPC341
Aflibercept
Status:
UmsóknApplication date:
30.6.2021Application published:
15.7.2021
Max expiry date:
25.11.2027Medicine name:
EYLEAMedicine for children:
No
Timeline
Today
30.6.2021Application
15.7.2021Publication
25.11.2027Expires
Marketing license
IS authorization number:
EU/1/12/797/001-002Date:
13.12.2012
Foreign authorization number:
EU/1/12/797Date:
22.11.2012
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128 Reykjavík
Patent
Number:
EP2944306